TY - JOUR
T1 - The Association of Patent Ductus Arteriosus with Inflammation
T2 - A Narrative Review of the Role of Inflammatory Biomarkers and Treatment Strategy in Premature Infants
AU - Wei, Yu Jen
AU - Hsu, Rosie
AU - Lin, Yung Chieh
AU - Wong, Tak Wah
AU - Kan, Chung Dann
AU - Wang, Jieh Neng
N1 - Funding Information:
This work was supported by the Ministry of Science and Technology, Taiwan (MOST 108–2314-B-006-065 MY2; MOST-110–2314-B-006–048-MY2) granted to J.-N. Wang. This work was also funded by the intramural grant NCKUH-11105003 granted to Y.-J. Wei and T.-W. Wong acknowledges funding from National Cheng Kung University Hospital, Taiwan [NCKUH-11104041], and the Center of Applied Nanomedicine, National Cheng Kung University from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE). The APC was funded by NCKUH-11105003.
Publisher Copyright:
© 2022 by the authors.
PY - 2022/11
Y1 - 2022/11
N2 - Patent ductus arteriosus (PDA) is a common cardiovascular complication that complicates clinical care in the intensive care of premature infants. Prenatal and postnatal infections and the inflammation process can contribute to PDA, and intrauterine inflammation is a known risk factor of PDA. A variety of inflammatory biomarkers have been reported to be associated with PDA. Chorioamnionitis induces the fetal inflammatory process via several cytokines that have been reported to be associated with the presence of PDA and may have a role in the vascular remodeling process or vessel dilation of the ductus. On the other hand, anti-inflammatory agents, such as antenatal steroids, decrease PDA incidence and severity in patients born to those with chorioamnionitis. Proinflammatory cytokines, which are expressed more significantly in preterm neonates and chorioamnionitis, are associated with the presence of PDA. In this review, we focus on the pathogenesis of PDA in preterm infants and the role of biomarkers associated with the perinatal inflammatory process.
AB - Patent ductus arteriosus (PDA) is a common cardiovascular complication that complicates clinical care in the intensive care of premature infants. Prenatal and postnatal infections and the inflammation process can contribute to PDA, and intrauterine inflammation is a known risk factor of PDA. A variety of inflammatory biomarkers have been reported to be associated with PDA. Chorioamnionitis induces the fetal inflammatory process via several cytokines that have been reported to be associated with the presence of PDA and may have a role in the vascular remodeling process or vessel dilation of the ductus. On the other hand, anti-inflammatory agents, such as antenatal steroids, decrease PDA incidence and severity in patients born to those with chorioamnionitis. Proinflammatory cytokines, which are expressed more significantly in preterm neonates and chorioamnionitis, are associated with the presence of PDA. In this review, we focus on the pathogenesis of PDA in preterm infants and the role of biomarkers associated with the perinatal inflammatory process.
UR - http://www.scopus.com/inward/record.url?scp=85142788123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142788123&partnerID=8YFLogxK
U2 - 10.3390/ijms232213877
DO - 10.3390/ijms232213877
M3 - Review article
C2 - 36430355
AN - SCOPUS:85142788123
SN - 1661-6596
VL - 23
JO - International journal of molecular sciences
JF - International journal of molecular sciences
IS - 22
M1 - 13877
ER -